Search
for
Sort by
Research 451–480 of 1000+
- Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems
- 5α-Reduced glucocorticoids: a story of natural selection
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Acquired scalp alopecia. Part I: A review
- Mitoxantrone
- Acne in the adult female patient: a practical approach
- Toward a Diagnostic Score in Cushing's Syndrome
- Female type of adult acne: Physiological and psychological considerations and management
- Evidence-based approach to cutaneous hyperandrogenism in women
- Mood disorders and quality of life in polycystic ovary syndrome
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Cutaneous Side Effects of Oral Contraceptives
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Comprehensive analysis of circRNAs from cashmere goat skin by next generation RNA sequencing (RNA-seq)
- Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer
- Side effects of common acne treatments
- Hormonal changes in menopause: do they contribute to a ‘midlife hair crisis’ in women?
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- One of These Things Is Not Like the Others: The Idea of Precedence in Health Technology Assessment and Coverage Decisions
- Androgens in women
- Gender-Affirming Hormone Therapy for Transgender Females
- Acne in women
- Polycystic ovary syndrome: A review for dermatologists
- Understanding and Management of Female Pattern Alopecia
- ANDROGENETIC ALOPECIA
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome